Vascular Sealant

About Tissium

TISSIUM is a private, clinical-stage medtech company pioneering a platform of biomorphic programmable polymers for tissue reconstruction. The company has achieved its first commercial milestone with the FDA De Novo authorization of COAPTIUM® CONNECT for sutureless nerve repair in the United States. With an integrated innovation and manufacturing platform, TISSIUM is advancing a pipeline across peripheral nerve, cardiovascular, and gastrointestinal therapeutic areas, leveraging both internal development and industry co-development partnerships. The company represents a convergence of advanced material science and surgical device development.

Therapeutic Areas